𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety Evaluation of Monophosphoryl Lipid A (MPL): An Immunostimulatory Adjuvant

✍ Scribed by Paul Baldrick; Derek Richardson; Gary Elliott; Alan W. Wheeler

Book ID
115647120
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
167 KB
Volume
35
Category
Article
ISSN
0273-2300

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety evaluation of a new allergy vacci
Safety evaluation of a new allergy vaccine containing the adjuvant monophosphoryl lipid A (MPL®) for the treatment of grass pollen allergy
✍ Paul Baldrick; Derek Richardson; Alan W. Wheeler; Stefan R. Woroniecki 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

## Abstract A novel allergy vaccine (Pollinex^®^ Quattro) has been developed for the prevention or relief of allergic symptoms caused by a variety of pollens. Within this range, the grass pollen allergy vaccine contains extracts of 12 grass pollens and rye cereal (all chemically modified by glutaral

Pollinex® Quattro Ragweed: safety evalua
Pollinex® Quattro Ragweed: safety evaluation of a new allergy vaccine adjuvanted with monophosphoryl lipid A (MPL®) for the treatment of ragweed pollen allergy
✍ Paul Baldrick; Derek Richardson; Stefan R. Woroniecki; Beverley Lees 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

## Abstract A novel allergy vaccine (Pollinex^®^ Quattro Ragweed) has been developed for the prevention or relief of allergic symptoms caused by pollen from __Ambrosia__ spp. (ragweed). An extract from the pollen (chemically modified by glutaraldehyde) is adsorbed onto l‐tyrosine with addition of t